Abstract
New hypoglycemic drugs, including glucagon-like peptide 1 receptor agonists (GLP-1RA), dipeptidyl peptidase-4 inhibitors (DPP-4i) and sodium-glucose c......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
